Global Personalized Medicine Market: Industry Analysis and Forecast (2020-2026) By Product, Application, Technology, End-Users and Region

Global Personalized Medicine Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 10.5% during forecast period.

Global Personalized Medicine Market Overview:

Personalized medicine is an emerging field of, medicine which is also referred to as precision medicine. This medical model uses an individual’s genetic profile to guide decisions made in regard to the prevention, diagnosis, and treatment of disease. Knowledge of a patient's genetic profile can help doctors select the proper medication or therapy and administer it using the proper dose or regimen. Personalized medicine is being advanced through data from the Human Genome Project.

Global Personalized Medicine Market Dynamics:

Dominantly increasing cases of various cancers worldwide primarily drive the market growth.

The rising prevalence of cancer and the rising demand for personalized cancer therapeutics boost the market growth. Growing incidences of technological advancements owing to the accessibility of large scale human genome databases including Next Generation Sequencing (NGS) positively impacts market growth. The use of advanced computational tools and the development of innovative genetic technologies help in identifying cancer causes. Recent developments in pharmacogenomics are expected to create a suitable environment for developing drugs, which are specific to one patient or group. Increasing therapeutic applications in the fields like cardio-renal, neurology, antiviral, pulmonary, psychiatry are expected to create potential growth opportunity in forecast years. However, complex nature of these drugs, high development costs, and variability effects amongst the patients are some factors that may restrain the market growth. The report has profiled eighteen key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed.

Global Personalized Medicine Market Segment Analysis:

The global Personalized Medicine Market is segment on the basis of product, application, technology and end-users. Based on Product, the personalized nutrition & wellness segment held the largest share of XX% in 2019. It is expected to grow at a CAGR of 8.3% during the forecast period. Rising awareness of consuming healthy food for wellness, an increase in adoption of customized diet plans are considered to be the major factors propelling the segment growth. A wide range of nutrition & wellness products are available which play a significant role in boosting segment growth. In March 2018, DSM partnered with Mixfit to provide personalized nutrition solutions by combining Artificial Intelligence (AI) technology. Based on Technology, the drug discovery segment is expected to dominate the global market. Recent technological advancements in drug discovery and pharmacogenomics contribute to boosting the market growth. Pharmacogenomics is used in predicting the efficacy of a drug. Pharmacogenomics helps in focusing effective therapy on smaller patient subpopulations that, although demonstrate the same disease phenotype but have distinct genetic profiles. The segment is estimated to grow at a CAGR of 8.7% during the forecast period. In October 2018, Qiagen announced its launch of novel RNA-seq library preparation solutions for next-generation sequencing thereby expanding its portfolio and user base significantly. Global Personalized Medicine Market by Application To know about the Research Methodology :- Request Free Sample Report

Global Personalized Medicine Market Regional Insights:

Global Personalized Medicine Market by Regional

North America held a prominent market share of XX% in 2019.

Due to Huge investments in the healthcare industry, the market for personalized medicine is expected to be dominated by the North America region followed by Europe. The increasing prevalence of cancer in the region and increased demand for precision medicine is attributed to the favorable government initiatives and growing investments for the development of novel solutions for effective disease management. Various initiatives undertaken will pave the market growth by creating awareness about personalized medicines.

APAC is expected to grow at a significant CAGR during forecast period.

Owing to the low cost of clinical trials of newly developed precision medicines and diagnostic products. Moreover, rising disposable income levels and the growing economy of emerging countries will boost the market further. The report also helps in understanding Global Personalized Medicine Market dynamics, structure by analyzing the market segments and project the Global Personalized Medicine Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Personalized Medicine Market make the report investor’s guide.

Global Personalized Medicine Market Scope: Inquire before buying

Global Personalized Medicine Market by Scope

Global Personalized Medicine Market, by Region:

• North America • Europe • South America • MEA • APAC

Global Personalized Medicine Market Key Players

• Abbott Laboratories • Merck & Co., Inc. • AstraZeneca • Pfizer, Inc. • GlaxoSmithKline plc. • Novartis AG • Amgen, Inc. • Bayer AG • Mylan N.V. • Eli Lilly and Company • Bristol Myers Squibb Co. • Daiichi Sankyo Company, Ltd. • Biogen, Inc. • Johnson & Johnson Services, Inc. • F. Hoffmann-La Roche Ltd. • Thermo Fisher Scientific, Inc. • Novo Nordisk A/S • Sanofi Genzyme.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Personalized Medicine Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Personalized Medicine Market 3.4. Geographical Snapshot of the Personalized Medicine Market, By Manufacturer share 4. Global Personalized Medicine Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Personalized Medicine Market 5. Supply Side and Demand Side Indicators 6. Global Personalized Medicine Market Analysis and Forecast, 2019-2026 6.1. Global Personalized Medicine Market Size & Y-o-Y Growth Analysis. 7. Global Personalized Medicine Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 7.1.1. Personalized Medical Care 7.1.2. Therapeutics 7.1.3. Personalized Nutrition & Wellness 7.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 7.2.1. Oncology 7.2.2. Immunology 7.2.3. CNS 7.2.4. Respiratory 7.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 7.3.1. Big Data Analytics 7.3.2. Bioinformatics 7.3.3. Gene Sequencing 7.3.4. Drug Discovery 7.3.5. Companion Diagnostics 7.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 7.4.1. Pharmaceutical Companies 7.4.2. Diagnostic Companies 7.4.3. Healthcare IT companies 8. Global Personalized Medicine Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Personalized Medicine Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 9.1.1. Personalized Medical Care 9.1.2. Therapeutics 9.1.3. Personalized Nutrition & Wellness 9.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 9.2.1. Oncology 9.2.2. Immunology 9.2.3. CNS 9.2.4. Respiratory 9.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 9.3.1. Big Data Analytics 9.3.2. Bioinformatics 9.3.3. Gene Sequencing 9.3.4. Drug Discovery 9.3.5. Companion Diagnostics 9.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 9.4.1. Pharmaceutical Companies 9.4.2. Diagnostic Companies 9.4.3. Healthcare IT companies 10. North America Personalized Medicine Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Personalized Medicine Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 11.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 11.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 12. Canada Personalized Medicine Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 12.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 12.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 13. Mexico Personalized Medicine Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 13.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 13.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 14. Europe Personalized Medicine Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 14.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 14.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 15. Europe Personalized Medicine Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Personalized Medicine Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 16.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 16.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 17. France Personalized Medicine Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 17.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 17.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 18. Germany Personalized Medicine Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 18.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 18.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 19. Italy Personalized Medicine Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 19.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 19.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 20. Spain Personalized Medicine Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 20.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 20.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 21. Sweden Personalized Medicine Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 21.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 21.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 22. CIS Countries Personalized Medicine Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 22.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 22.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 23. Rest of Europe Personalized Medicine Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 23.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 23.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 24. Asia Pacific Personalized Medicine Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 24.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 24.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 25. Asia Pacific Personalized Medicine Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Personalized Medicine Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 26.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 26.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 27. India Personalized Medicine Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 27.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 27.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 28. Japan Personalized Medicine Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 28.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 28.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 29. South Korea Personalized Medicine Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 29.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 29.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 30. Australia Personalized Medicine Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 30.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 30.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 31. ASEAN Personalized Medicine Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 31.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 31.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 32. Rest of Asia Pacific Personalized Medicine Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 32.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 32.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 33. Middle East Africa Personalized Medicine Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 33.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 33.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 34. Middle East Africa Personalized Medicine Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Personalized Medicine Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 35.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 35.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 36. GCC Countries Personalized Medicine Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 36.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 36.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 37. Egypt Personalized Medicine Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 37.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 37.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 38. Nigeria Personalized Medicine Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 38.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 38.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 39. Rest of ME&A Personalized Medicine Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 39.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 39.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 40. South America Personalized Medicine Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 40.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 40.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 41. South America Personalized Medicine Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Personalized Medicine Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 42.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 42.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 43. Argentina Personalized Medicine Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 43.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 43.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 44. Rest of South America Personalized Medicine Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Product, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 44.3. Market Size (Value) Estimates & Forecast By Technology, 2019-2026 44.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Personalized Medicine Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Abbott Laboratories 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Merck & Co., Inc. 45.3.3. AstraZeneca 45.3.4. Pfizer, Inc. 45.3.5. GlaxoSmithKline plc. 45.3.6. Novartis AG 45.3.7. Amgen, Inc. 45.3.8. Bayer AG 45.3.9. Mylan N.V. 45.3.10. Eli Lilly and Company 45.3.11. Bristol Myers Squibb Co. 45.3.12. Daiichi Sankyo Company, Ltd. 45.3.13. Biogen, Inc. 45.3.14. Johnson & Johnson Services, Inc. 45.3.15. F. Hoffmann-La Roche Ltd. 45.3.16. Thermo Fisher Scientific, Inc. 45.3.17. Novo Nordisk A/S 45.3.18. Sanofi Genzyme 46. Primary Key Insights

About This Report

Report ID91666
Category Healthcare
Published DateApril 2021
Updated DateNov 2021
Contact Us